focus -WSS

focus

author：entertainment 2025-09-30 00:45:38 - browse：19

Eli Lilly said Friday it will acquire Versanis Bio, a private company developing an obesity drug that specifically targets fat mass, as the race among pharmaceutical companies to offer weight loss medications intensifies.

The deal indicates Lilly is aiming to diversify its growing portfolio of weight loss therapies, as Versanis’ drug employs an entirely different mechanism than the existing obesity drugs that Lilly is studying. The pharma giant didn’t say how much it would pay Versanis upfront, but said that if the drug meets certain milestones, the total payment could reach $1.9 billion.

Lilly, along with other pharma companies like Novo Nordisk, has been developing products in the class of GLP-1 drugs, which mimic the glucagon-like peptide 1 hormone that helps people feel full. These drugs – including Novo’s Ozempic and Wegovy, and Lilly’s Mounjaro – have exploded in popularity because they lead to significant weight loss.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Biden’s NIH nominee is languishing in Congress

WSS

Wisconsin governor employs partial veto to fund schools for 4 centuries

The U.S. needs a new definition of substance use “recovery”

Clinicians often fail to acknowledge the pain caused by long Covid

Hospitals need to get ahead of regulations on climate change

The Bio Revolution is changing business and society

Home health providers sue Medicare over payment cuts

hotspot

focus

knowledge

Trump demands the U.S. pay no more for drugs than other countries … again

Guardant Health colon cancer test endorsed by FDA advisory panel

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Asahi Kasei to buy Calliditas, picking up kidney disease drug

New air purifier tech could be key to improving indoor air quality

Teachers share how revamped forgiveness program helped with their student loans

Hepatitis C has a cure — but many Americans still lack access to it

Why some fertility treatments produce more boy babies

Alkermes shareholders re

The Bio Revolution is changing business and society

hotspot

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

J&J reports mixed data on next

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

Stroke rates rising, especially in working

Louisiana bill approved classifying abortion pills as controlled substances

hotspot

hotspot

hotspot

focus